INVESTOR NEWS

Apr 30, 2025

Gentian Diagnostics: Invitation to presentation of first quarter results

Gentian Diagnostics ASA will present its first quarter 2025 results on 7 May 2025 at 10.00 CEST.

Apr 07, 2025

Mandatory notification of trade

Moss, 7 April 2025

Dec 04, 2024

Financial calendar

Financial calendar for Gentian Diagnostics ASA

Nov 26, 2024

Gentian Diagnostics presents at the DNB Nordic Healthcare Conference

Moss, 26 November 2024

Oct 10, 2024

Gentian Diagnostics announces the death of its founder Dr. Erling Sundrehagen

Moss, 10 October 2024

Aug 22, 2024

Gentian Diagnostics: Invitation to presentation of second quarter results

Gentian Diagnostics ASA will present its second quarter 2024 results on August 29th at 10.00 am.

Jul 31, 2024

Gentian Diagnostics presents its NT-proBNP prototype at the ADLM

Chicago, 31 July 2024

Jul 22, 2024

Matti Heinonen (Arvela) appointed as CEO of Gentian Diagnostics 

Moss, 22 July 2024

Feb 09, 2024

Gentian Diagnostics ASA: Fourth quarter and full year 2023 report

Moss, 9 February 2024

Dec 19, 2023

Disclosure of shareholding

Viola AS, a wholly-owned subsidiary of Rasmussengruppen AS, acquired 150,000 shares in Gentian Diagnostics..